Advertisement

In 2022, the Probe-Based Reagents Segment is Expected to Dominate the Market Due to its Benefits Over the Dye-Based Such as More Exact Results in Lesser Time than Dye-Based

These diseases include cardiac diseases, cancer, and diabetes, which are the leading causes of death and disability in many countries around the globe. Q-PCR reagents are essential for the diagnosis of chronic diseases such as human immuno deficiency virus (HIV) and malaria. Both conditions have non-specific symptoms. The q-PCR kits and mixers contain all the necessary PCR reagents for rapid, sensitive, and reproducible real-time detection of HIV and other diseases using highly specific primer pairs.  

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-q-pcr-reagents-market

The Global q-PCR Reagents Market is expected to reach USD 1,573.30 million by 2029 from USD 982.47 million in 2021, growing at a CAGR of 6.6% in the forecast period of 2022 to 2029. The rise in FDA approval and the presence of major market players are rising the market growth. The rising government investments with the rising strategic initiatives by major market players are giving an opportunity to the market to enhance the treatment. However, the increasing product recall is challenging the market growth.

q-PCR Reagents Market

Increasing cases of chronic diseases globally is expected to drive the market's growth rate

In the Center for Disease Control and Prevention (CDC) data, the World Health Organization's World Malaria Report 2020 that 50% of the world's population lives at risk of malaria transmission in 87 countries and territories. The data also states that malaria caused around 229 million clinical episodes. In the WHO African Region, an estimated 94% of deaths occurred due to malaria. According to the Data from the 2018 National Health Interview Survey (NHIS), in the U.S., more than half (51.8%) of adults had at least 1 of 10 selected diagnosed chronic conditions (arthritis, cancer, chronic obstructive pulmonary disease, coronary heart disease, current asthma, diabetes, hepatitis, hypertension, stroke, and weak or failing kidneys), and 27.2% of us adults had multiple chronic conditions. This will positively affect the market growth rate.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014-2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Detection Type (Dye -Based Reagents and Probe -Based Reagents), Assay Type (Q-PCR Singleplex Test/Assay and Q-PCR Multiplex Test/Assay), Plexity (Dye -Based Reagents and Probe -Based Reagents), Packaging Type (Kits and Master Mixes), Technology (Gene Expression, Gene Typing, MIRNA Analysis, Pre-Amplification and Virus Detection), Application (Diagnostics, Research and Forensic), End User (Hospital and Diagnostic Centers, Forensic Laboratories, Research and Academic Institute, Clinical Research Organization, and Others), Distribution Channel (Direct Tender, Third Party Distributors, and Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Hollister Incorporated (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc (U.S.), Biotium (U.S.), MiRXES Pte Ltd (Singapore), GeneDireX, Inc (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Norgen  Biotek Corp (Canada), Takara Holdings Inc. (Japan), Enzo Biochem Inc (U.S.), Qiagen (Germany), PCR Biosystems (U.K.), Tonbo Biosciences (U.S.), Quantabio (U.S.), Merck KgaA (Germany), Kaneka Eurogentec S.A (Japan), Promega Corporation (U.S.), Solis BioDyne (Estonia), Seegene Inc. (South Korea), Sino Biological Inc (China), Thermo Fisher Scientific Inc (U.S.), TRANSGENE BIOTEK LIMITED (India), New England Biolabs (U.S.), Empirical Bioscience, Inc. (U.S.), YouSeq Ltd (U.K.), and Bioneer Corporation (South Korea) among others            

Data Points Covered in the Report

In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework

Segment Analysis:

The q-PCR reagents market is segmented on the basis of detection type, assay type, plexity type, packaging type, application, technology, end user and distribution channel.

  • On the basis of detection type, the global q-PCR reagents market is segmented into dye -based reagents and probe -based reagents. In 2022, dye-based reagents segment will dominate the global q-PCR reagents market with 54.93% market share due to its benefits over the dye-based such as more exact results in less time than dye-based.

Probe-based reagents is expected to dominate the market during the forecast period

Probe-based reagents is more specific and sensitive and at each cycle of a PCR, the probe-based reagents used as a target-specific probe to measure DNA amplification. It yields increased sensitivity in the samples.

  • On the basis of assay type, the global q-PCR reagents market is segmented into q-PCR singleplex test/assay and q-PCR multiplex test/assay. In 2022, q-PCR singleplex test/assay segment is expected to dominate the global q-PCR reagents market due to the increasing chronic and communicable diseases.
  • On the basis of plexity type, the global q-PCR reagents market is segmented into dye -based reagents and probe -based reagents. In 2022, the dye-based reagents segment is expected to dominate the global q-pcr reagents market with 54.93% market share due to its benefits and advantages over other reagents.
  • On the basis of packaging type, the global q-PCR reagents market is segmented into kits and master mixes. In 2022, the kits segment is expected to dominate the global q-PCR reagents market with 77.05% market share due to the accessibility of core kits across the major countries, minimal prices, expanding private-public finance for life science research, and suppleness offered to end-users.  
  • On the basis of technology, the global q-PCR reagents market is segmented into gene expression, gene typing, MIRNA analysis, pre-amplification, and virus detection. In 2022, the gene expression is expected to dominate the market with 38.55% market share due to its credible precision and high-throughput competence.
  • On the basis of application, the global q-PCR reagents market is segmented into diagnostics, research, and forensic. In 2022, the forensic application is expected to grow in the market with 62.20% market share due to mounting frequencies of criminal cases, and increasing laboratory automation in forensic laboratories.
  • On the basis of end user, the global q-PCR reagents market is segmented into hospital & diagnostic centers, forensic laboratories, research & academic institute, clinical research organization and others. In 2022, the hospital & diagnostic centers segment is expected to dominate the market with 47.40% market share due to the immense amount of diagnosis and testing required to support a disease discovery and development.

Hospital & diagnostic centers segment is expected to dominate the q-PCR reagents in 2022

The hospitals and diagnostic segment is expected to flourish owing to the rising number of healthcare facilities in the developing economies. Also, rising number of research and drug development activities will further propel this segment's growth.

  • On the basis of distribution channel, the global q-PCR reagents market is segmented into direct tender, third party distributors and others. In 2022, direct tender is expected to dominate the global q-PCR reagents market with 56.74% market share as direct tender is an easy process that does not involve any other medium for supply.

Major Players

Data Bridge Market Research recognizes the following companies as the market players in the market: Hollister Incorporated (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc (U.S.), Biotium (U.S.), MiRXES Pte Ltd (Singapore), GeneDireX, Inc (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Norgen  Biotek Corp (Canada), Takara Holdings Inc. (Japan), Seegene Inc. (South Korea), Sino Biological Inc (China), Thermo Fisher Scientific Inc (U.S.), TRANSGENE BIOTEK LIMITED (India), New England Biolabs (U.S.), Empirical Bioscience, Inc. (U.S.), YouSeq Ltd (U.K.), and Bioneer Corporation (South Korea).

q-PCR Reagents Market

Market Development

  • US FDA approved an Emergency Use Authorization (EUA) for Bio-SARS-CoV-2 Rad's ddPCR Kit to detect SARS-CoV-2 infection in September 2020. Furthermore, regulatory agencies have expressed strong support for the approval of these tests in order to reduce the impact of the COVID-19 outbreak.
  • Biotium will release EvaRuby Dye for qPCR and HRM in November 2021. This spectrally distinct red fluorescent intercalating dye can be incorporated into probe-based qPCR assays, expanding probe-based qPCR multiplexing options. This has increased the company's product portfolio.
  • Takara Holding Inc. announced the implementation of a Center for Gene and Cell Processing (CGCP) manufacturing facility in November 2021, with the goal of developing a domestic supply chain for important reagents, including PCR testing reagents. This has resulted in increased production and sales for the company.
  • In February 2020, Promega Corporation, a global biotechnology manufacturer launched Wizard MW DNA extraction kit. The Wizard MW DNA extraction kit was launched for research work involving fragments of genomic DNA. This development will promote the growth and expansion of the company portfolio. 

Regional Analysis

Geographically, the countries covered in the q-PCR reagents market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

As per Data Bridge Market Research analysis:

North America is the dominant region in q-PCR reagents market during the forecast period 2022 - 2029

North America is dominating the q-PCR reagents market owing to the higher level of investments by U.S. manufacturers and increasing prevalence of diabetes in U.S.  North America will continue to dominate the advanced wound care market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the growing adoption of advanced technology and launch of new products in this region. Additionally, the increasing number of cases of chronic wounds and the rising geriatric population are expected to further enhance the market's growth rate in this region. 

Asia-Pacific is estimated to be the fastest-growing region in q-PCR reagents market the forecast period 2022 - 2029

Asia-Pacific is expected to grow during the forecast period due to the presence of major market players and rapid development of medical facilities in emerging economies in this region. In addition, rising healthcare expenditure and increasing per-capita income are expected to propel the market's growth rate in this region.

COVID-19 Impact Analysis

The pandemic of COVID-19 has had a significant impact on the healthcare industry. The diagnostic industry was the hardest hit, with the market growing at an exponential rate. Digital PCR and real-time PCR have sparked a lot of interest because they are used for diagnostics and drug development. As a result, industry vendors are increasingly concentrating on developing droplet digital PCR kits to detect COVID-19. Furthermore, many market participants have introduced novel instruments and tests for COVID-19 testing. For example, the US FDA approved an Emergency Use Authorization (EUA) for Bio-SARS-CoV-2 Rad's ddPCR Kit for the detection of SARS-CoV-2 infection in September 2020. Furthermore, regulatory agencies have expressed strong support for the approval of these tests in order to reduce the impact of the COVID-19 outbreak. As a result, market growth will be boosted.  

For more detailed information about the q-PCR reagents market report, click here – https://www.databridgemarketresearch.com/reports/global-q-pcr-reagents-market